These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25901073)

  • 21. Bosentan and sildenafil: should the combination therapy be a valid alternative in childhood to prostacyclin infusion?
    Brancaccio G; Toscano A; Bevilacqua M; Di Chiara L; Parisi F
    Pediatr Transplant; 2007 Feb; 11(1):110-2. PubMed ID: 17239133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pulmonary hypertension treatment: future prospects].
    Baloira A
    Arch Bronconeumol; 2007 Mar; 43(3):131-5. PubMed ID: 17386188
    [No Abstract]   [Full Text] [Related]  

  • 23. Patent ductus arteriosus.
    Schneider DJ; Moore JW
    Circulation; 2006 Oct; 114(17):1873-82. PubMed ID: 17060397
    [No Abstract]   [Full Text] [Related]  

  • 24. Right ventricular diastolic dysfunction and the acute effects of sildenafil in pulmonary hypertension patients.
    Gan CT; Holverda S; Marcus JT; Paulus WJ; Marques KM; Bronzwaer JG; Twisk JW; Boonstra A; Postmus PE; Vonk-Noordegraaf A
    Chest; 2007 Jul; 132(1):11-7. PubMed ID: 17625080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sildenafil as a substitute for subcutaneous prostacyclin in pulmonary hypertension].
    Cea-Calvo L; Escribano Subías P; Tello de Menesses R; Gómez Sánchez MA; Delgado Jiménez JF; Sáenz de la Calzada C
    Arch Bronconeumol; 2003 Oct; 39(10):476-7. PubMed ID: 14533998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Should right ventricle dilatation during exercise have clinical implications in patients with chronic thromboembolic pulmonary hypertension? Case report.
    Cotrim C; Loureiro MJ; Miranda R; Almeida S; Almeida AR; Simões O; Cordeiro P; Carrageta M
    Cardiovasc Ultrasound; 2007 Dec; 5():50. PubMed ID: 18162132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patent ductus arteriosus with Eisenmenger syndrome.
    Moustafa S; Patton DJ; Balon Y; Connelly MS; Alvarez N
    Heart Lung Circ; 2013 Nov; 22(11):968-9. PubMed ID: 23583537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology.
    D'Alto M; Romeo E; Argiento P; Sarubbi B; Santoro G; Grimaldi N; Correra A; Scognamiglio G; Russo MG; Calabrò R
    Int J Cardiol; 2012 Mar; 155(3):378-82. PubMed ID: 21081251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Giant pulmonary trunk with Eisenmenger flow through patent ductus arteriosus.
    Nanba T; Funabashi N; Takahara M; Takaoka H; Ozawa K; Kobayashi Y
    Int J Cardiol; 2016 Feb; 204():248-51. PubMed ID: 26682956
    [No Abstract]   [Full Text] [Related]  

  • 30. Lung Perfusion Scintigraphy in Eisenmenger Syndrome Due to Patent Ductus Arteriosus.
    Mitsui K; Woodhams R; Ukisu R; Inoue Y
    Clin Nucl Med; 2019 Nov; 44(11):879-880. PubMed ID: 31361645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An evidence-based approach to the management of pulmonary arterial hypertension.
    Archer SL; Michelakis ED
    Curr Opin Cardiol; 2006 Jul; 21(4):385-92. PubMed ID: 16755209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Doppler ghost in the pulmonary artery.
    Cagli K; Ozbulbul NI; Ozeke O; Calapkulu MY; Golbasi Z
    Echocardiography; 2020 Mar; 37(3):472-473. PubMed ID: 32092170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful Pulmonary Artery Embolization for the Management of Hemoptysis in a Patient with Eisenmenger Syndrome Caused by Patent Ductus Arteriosus.
    Tamada N; Nakayama K; Shinkura Y; Yanaka K; Katayama N; Okada T; Yamaguchi M; Matsumoto K; Tanaka H; Shinke T; Emoto N; Hirata KI
    Intern Med; 2017 Dec; 56(24):3299-3304. PubMed ID: 29021475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension.
    Diller GP; van Eijl S; Okonko DO; Howard LS; Ali O; Thum T; Wort SJ; Bédard E; Gibbs JS; Bauersachs J; Hobbs AJ; Wilkins MR; Gatzoulis MA; Wharton J
    Circulation; 2008 Jun; 117(23):3020-30. PubMed ID: 18519847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bosentan treatment in an adult with pulmonary hypertension due to patent ductus arteriosus permits surgical repair.
    Mitropoulos FA; Apostolopoulou SC; Kanakis MA; Rammos S; Anagnostopoulos CE
    J Heart Lung Transplant; 2007 Dec; 26(12):1345-6. PubMed ID: 18096490
    [No Abstract]   [Full Text] [Related]  

  • 36. Bosentan treatment for pulmonary arterial hypertension due to patent ductus arteriosus and Down's syndrome in an infant.
    He J; Ren Y; Chen Y; Feng Y
    Int J Cardiol; 2014 Oct; 176(3):e117-8. PubMed ID: 25129297
    [No Abstract]   [Full Text] [Related]  

  • 37. Transcatheter intervention following bosentan-iloprost treatment in a patient with patent ductus arteriosus and pulmonary hypertension.
    Guzeltas A; Odemis E; Bilici M; Tanidir IC; Özyılmaz İ
    Int J Cardiol; 2012 Jan; 154(2):e40-1. PubMed ID: 21640402
    [No Abstract]   [Full Text] [Related]  

  • 38. [Role of the Rho-kinase pathway in pulmonary arterial hypertension].
    Fukumoto Y
    Nihon Yakurigaku Zasshi; 2014 Apr; 143(4):178-81. PubMed ID: 24717605
    [No Abstract]   [Full Text] [Related]  

  • 39. Idiopathic pulmonary arterial hypertension.
    Souza R; Jardim C; Humbert M
    Semin Respir Crit Care Med; 2013 Oct; 34(5):560-7. PubMed ID: 24037625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of pulmonary vasodilator therapy on ventilatory efficiency during exercise in adults with Eisenmenger syndrome.
    Yang-Ting S; Aboulhosn J; Sun XG; Child JS; Sietsema KE
    Congenit Heart Dis; 2011; 6(2):139-46. PubMed ID: 21418531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.